Literature DB >> 15177003

Sclerotic metaphyseal lines in a child treated with pamidronate: histomorphometric analysis.

Frank Rauch1, Rose Travers, Craig Munns, Francis H Glorieux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15177003     DOI： 10.1359/JBMR.040303

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN： 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  19 in total

Review 1.  Treatment of children with osteogenesis imperfecta.

Authors:  Frank Rauch; Francis H Glorieux
Journal:  Curr Osteoporos Rep       Date:  2006-12       Impact factor: 5.096

2.  Can bisphosphonate treatment be stopped in a growing child with skeletal fragility?

Authors:  K A Ward; J E Adams; T J Freemont; M Z Mughal
Journal:  Osteoporos Int       Date:  2007-02-06       Impact factor: 4.507

3.  Bisphosphonate-induced zebra lines in fibrous dysplasia of bone: histo-radiographic correlation in a case of McCune-Albright syndrome.

Authors:  Alessandro Corsi; Ernesto Ippolito; Pamela G Robey; Mara Riminucci; Alan Boyde
Journal:  Skeletal Radiol       Date:  2017-06-28       Impact factor: 2.199

Review 4.  Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment.

Authors:  P Trejo; F Rauch
Journal:  Osteoporos Int       Date:  2016-08-05       Impact factor: 4.507

5.  Denosumab treatment for fibrous dysplasia.

Authors:  Alison M Boyce; William H Chong; Jack Yao; Rachel I Gafni; Marilyn H Kelly; Christine E Chamberlain; Carol Bassim; Natasha Cherman; Michelle Ellsworth; Josephine Z Kasa-Vubu; Frances A Farley; Alfredo A Molinolo; Nisan Bhattacharyya; Michael T Collins
Journal:  J Bone Miner Res       Date:  2012-07       Impact factor: 6.741

6.  Pamidronate treatment stimulates the onset of recovery phase reducing fracture rate and skeletal deformities in patients with idiopathic juvenile osteoporosis: comparison with untreated patients.

Authors:  Giampiero I Baroncelli; Francesco Vierucci; Silvano Bertelloni; Paola Erba; Elisa Zampollo; Maria Rita Giuca
Journal:  J Bone Miner Metab       Date:  2013-04-03       Impact factor: 2.626

7.  Effect of bisphosphonates on the rapidly growing male murine skeleton.

Authors:  Eric D Zhu; Leeann Louis; Daniel J Brooks; Mary L Bouxsein; Marie B Demay
Journal:  Endocrinology       Date:  2014-01-14       Impact factor: 4.736

8.  Effects of denosumab treatment and discontinuation on human growth plates.

Authors:  Howard D Wang; Alison M Boyce; Jeffrey Y Tsai; Rachel I Gafni; Frances A Farley; Josephine Z Kasa-Vubu; Alfredo A Molinolo; Michael T Collins
Journal:  J Clin Endocrinol Metab       Date:  2014-01-01       Impact factor: 5.958

Review 9.  Osteogenesis Imperfecta: update on presentation and management.

Authors:  Moira S Cheung; Francis H Glorieux
Journal:  Rev Endocr Metab Disord       Date:  2008-04-11       Impact factor: 6.514

10.  Long Term Cyclic Pamidronate Reduces Bone Growth by Inhibiting Osteoclast Mediated Cartilage-to-Bone Turnover in the Mouse.

Authors:  K D Evans; L E Sheppard; D I Grossman; S H Rao; R B Martin; A M Oberbauer
Journal:  Open Orthop J       Date:  2008-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.